bioRxiv · 10.1101/2023.08.29.555049
Lysosomal MLKL is balanced by ESCRT to control cell death
Abstract
Mixed lineage kinase-like (MLKL) is activated by RHIM-domain containing kinase (RIPK)3 to permeabilize the plasma-membrane and execute necroptosis, a form of regulated necrosis. We found that MLKL is activated in an atypical, RIPK3- and necroptosis-independent manner downstream of Toll-like receptor 3, resulting in its translocation to lysosomes and lysosomal membrane permeabilization. Damaged lysosomes then undergo exocytosis, leading to the integration of lysosomal MLKL into the plasma-membrane to trigger cell death. The ESCRT-machinery can repair damaged lysosomes and counteract cell death by packing lysosomal MLKL into intraluminal vesicles, which are subsequently released as extracellular vesicles. In this way, ESCRT-machinery balances life and death decisions by preventing lysosomal MLKL to reach its killing destination, which is the plasma-membrane.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Jamard, C., Gil, C., Castets, M., Ichim, G., Weber, K.. 2023-08-30. Lysosomal MLKL is balanced by ESCRT to control cell death. https://doi.org/10.1101/2023.08.29.555049
Cite the original work for its findings. Save a collection to share your selection of sources.